AstraZeneca was hit with a patent infringement lawsuit Monday in Delaware District Court. The lawsuit, filed by Akin Gump Strauss Hauer & Feld and Farnan LLP on behalf of Bristol-Myers Squibb and E. R. Squibb & Sons LLC, asserts two patents related to developed checkpoint inhibitors that improve the abilities of a patients' immune system to target and kill cancer cells. Counsel have not yet appeared for the defendant. The case is 1:23-cv-00079, Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here: